EUVIMED · CrossrefJournal
JU Open Plus
ISSN 2771-554X · Ovid Technologies (Wolters Kluwer Health)
Latest articles
What Are Unmet Needs and Future Priorities in Ureteroscopic Stone Surgery? Insights From Clinicians, Scientists, and Industry
Evaluating the Influence of AUA Guidelines on Subsequent Research: A PubMed Analysis of Guideline Citation Rates
Time From Medication Order to Administration of Cabazitaxel vs Lutetium-177-PSMA-617 in Patients With Metastatic Castrate-Resistant Prostate Cancer
Management of Diverticular Colovesical Fistulas: A Single-Institution, Retrospective Analysis of Robotic, Laparoscopic, and Open Repair
Safety, Efficiency, and Environmental Impact of Virtual At-Home Catheter Removal After Robotic-Assisted Radical Prostatectomy
Editorial Comment: AI-Assisted Identification of the Testicular Artery During Microsurgical Varicocelectomy: A Feasibility Study
Editorial Comment: Surgical Team Composition and Outcomes After Radical Prostatectomy for Prostate Cancer
Robust Real-Time Stone Segmentation System Using Artificial Intelligence for Flexible Transurethral Lithotripsy in Hematuric Conditions
Indwelling Ureteral Stents Durometer and Diameter: Association With Obstruction and Symptoms
Editorial Comment: Safety, Efficiency and Environmental Impact of Virtual At-Home Catheter Removal After Robotic-Assisted Radical Prostatectomy
Reply to Editorial Comment: AI-Assisted Identification of the Testicular Artery During Microsurgical Varicocelectomy: A Feasibility Study
Reply to Editorial Comment: Propensity Score-Matched Comparison of Laparoscopic Transvesical Ureteral Reimplantation and Intravesical Open Ureterocystoneostomy for Primary Vesicoureteral Reflux: A Multicenter Study in Japan
Editorial Comment: Validation of Comprehensive Prostate Cancer Assessment on Sexual Health for Men Who Have Sex With Men (COMPASS)
Editorial Comment: Public Response to a Presidential Prostate Cancer Diagnosis: A Google Trends Analysis of Health Information Seeking Behavior
Surgical Team Composition and Outcomes After Radical Prostatectomy for Prostate Cancer
Editorial Comment: Micro-ultrasound Sagittal Length to Predict Clinically Significant Prostate Cancer in Lesions Visible on Both MRI and Micro-ultrasound (Dual-Image Visible Lesions)
Editorial Comment: Understanding Sociodemographic Barriers to Electronic Patient-Reported Outcome Completion: Experience with the WISQOL
Reply to Editorial Comment: Validation of Comprehensive Prostate Cancer Assessment on Sexual Health for Men Who Have Sex With Men (COMPASS)
Propensity Score–Matched Comparison of Laparoscopic Transvesical Ureteral Reimplantation and Intravesical Open Ureterocystoneostomy for Primary Vesicoureteral Reflux: A Multicenter Study in Japan
Reply to Editorial Comment: Understanding Sociodemographic Barriers to Electronic Patient-Reported Outcome Completion: Experience with the WISQOL
Editorial Comment: Propensity Score–Matched Comparison of Laparoscopic Transvesical Ureteral Reimplantation and Intravesical Open Ureterocystoneostomy for Primary Vesicoureteral Reflux: A Multicenter Study in Japan
October 2026 JUOP Editorial: The Value of Showing Up: Reflections From the MA-AUA Annual Meeting
Effect of Acupuncture on Urine Production and Storage in Prostate Cancer Survivors With Nocturia: Exploratory Analysis of a Randomized Clinical Trial
Clinical and Genomic Profiling of Early-Onset Bladder Cancer Identifies Key Alterations and Therapeutic Targets
Establishing Optimal Care Coordination for Localized Bladder Cancer in the United States: A Modified Delphi Consensus Study
Utilization of Emergency Services After Outpatient Urologic Surgery: A Retrospective Analysis
Validation of Comprehensive Prostate Cancer Assessment on Sexual Health for Men Who Have Sex With Men (COMPASS)
Micro-Ultrasound Sagittal Length to Predict Clinically Significant Prostate Cancer in Lesions Visible on Both MRI and Micro-Ultrasound (Dual-Image Visible Lesions)
Understanding Sociodemographic Barriers to Electronic Patient-Reported Outcome Completion: Experience With the WISQOL
Salvage Metastasis-Directed Therapy Without Androgen Deprivation for Positron Emission Tomography–Defined Oligorecurrent Prostate Cancer: Results of the SOAR Phase II Trial
EUVIMED